TO MODIFY THE CONTRACT AND ADD ADDITIONAL FUNDING TO CONFIGURE A SMARTPHONE AND WEB-BASED DIGITAL HEALTH SOLUTION TO SUPPORT THE GENERAL PUBLIC USE OF
修改合同并增加额外资金来配置智能手机和基于网络的数字健康解决方案,以支持公众使用
基本信息
- 批准号:10551163
- 负责人:
- 金额:$ 235.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-08 至 2022-06-07
- 项目状态:已结题
- 来源:
- 关键词:AppleCOVID-19 diagnosticCellular PhoneClinical TrialsCommunicationCommunitiesContractorContractsCustomDataData CollectionData Storage and RetrievalDiagnostic testsEnrollmentEnsureEventFeedbackFocus GroupsFrequenciesFundingFutureGeneral PopulationHealth Services AccessibilityHomeIndividualInstitutional Review BoardsInstructionInternetLanguageManualsMarket ResearchNational Institute of Biomedical Imaging and BioengineeringNotificationObservational StudyOnline SystemsParticipantPersonal Health RecordsPlayPrivacyPublic HealthReactionReadabilityReportingSecureSpecific qualifier valueSurveysSymptomsSystemTechnologyTest ResultTestingTimeVaccinationauthoritybasediariesdigitaldigital healthhandheld mobile devicehome testrepository
项目摘要
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) requires a system that can be managed by a study team and that will support general public use of SARS-CoV-2 diagnostic tests performed in a home setting. The platform must be easily accessible on a mobile device, support a variety of surveys, display test-specific usage instructions, provide guidance to the user on actions to take following test results, provide reminder notifications for test frequency, record the test results, integrate with technologies that provide test interpretation (as available), and report results to public health authorities as applicable and authorized by the user. It must additionally make all these data available to the study team for future analysis, when this is within the remit of the IRB approval for the study.
国家生物医学成像和生物工程研究所(NIBIB)需要一个可以由研究团队管理的系统,该系统将支持在家中进行的SARS-CoV-2诊断测试的一般公众使用。该平台必须在移动设备上易于访问,支持各种调查,显示特定于测试的使用说明,就采取后续测试结果的行动向用户提供指导,为测试频率提供提醒通知,记录测试结果,与提供测试解释的技术相结合(视情况而定),并在适用和用户授权的情况下向公共卫生当局报告结果。此外,它还必须向研究小组提供所有这些数据,以便在IRB批准该研究的范围内进行未来分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIK KHETERPAL其他文献
VIK KHETERPAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIK KHETERPAL', 18)}}的其他基金
TO MODIFY THE CONTRACT AND ADD ADDITIONAL FUNDING TO CONFIGURE A SMARTPHONE AND WEB-BASED DIGITAL HEALTH SOLUTION TO SUPPORT THE GENERAL PUBLIC USE OF
修改合同并增加额外资金来配置智能手机和基于网络的数字健康解决方案,以支持公众使用
- 批准号:
10506064 - 财政年份:2020
- 资助金额:
$ 235.81万 - 项目类别:
相似海外基金
Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.
等离子 PCR:快速护理点 COVID-19 诊断平台。
- 批准号:
422581 - 财政年份:2020
- 资助金额:
$ 235.81万 - 项目类别:
Operating Grants
Developing Multiplexed COVID-19 Diagnostic Methods for Medical Surveillance
开发用于医疗监测的多重 COVID-19 诊断方法
- 批准号:
555046-2020 - 财政年份:2020
- 资助金额:
$ 235.81万 - 项目类别:
Alliance Grants
Streamlining RNA extraction for widespread COVID-19 diagnostic testing
简化 RNA 提取以进行广泛的 COVID-19 诊断测试
- 批准号:
550402-2020 - 财政年份:2020
- 资助金额:
$ 235.81万 - 项目类别:
Alliance Grants
AgPlus Electrochemical COVID-19 Diagnostic Assay
AgPlus 电化学 COVID-19 诊断分析
- 批准号:
69258 - 财政年份:2020
- 资助金额:
$ 235.81万 - 项目类别:
Feasibility Studies
Enhancing National COVID-19 Diagnostic Support Capacity in Uganda
加强乌干达国家 COVID-19 诊断支持能力
- 批准号:
MC_PC_19062 - 财政年份:2020
- 资助金额:
$ 235.81万 - 项目类别:
Intramural